|
HBEGF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.56410000010199E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.0572999998888E-07 |
| Normal-vs-Stage2 |
3.88730000411286E-08 |
| Normal-vs-Stage3 |
3.73280000021126E-07 |
| Normal-vs-Stage4 |
1.05290000051994E-07 |
| Stage1-vs-Stage2 |
7.379000E-03 |
| Stage1-vs-Stage3 |
7.092600E-01 |
| Stage1-vs-Stage4 |
1.819570E-01 |
| Stage2-vs-Stage3 |
8.801600E-02 |
| Stage2-vs-Stage4 |
5.978600E-01 |
| Stage3-vs-Stage4 |
4.613200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4261000003124E-07 |
| Normal-vs-AfricanAmerican |
6.78170000045775E-07 |
| Normal-vs-Asian |
6.36550000043812E-07 |
| Caucasian-vs-AfricanAmerican |
1.360390E-01 |
| Caucasian-vs-Asian |
9.263400E-01 |
| AfricanAmerican-vs-Asian |
2.198400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80889999978895E-07 |
| Normal-vs-Female |
9.07769999947128E-07 |
| Male-vs-Female |
2.729800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55670000001606E-06 |
| Normal-vs-Extreme_Weight |
2.9949000002194E-07 |
| Normal-vs-Obese |
1.23259999984526E-07 |
| Normal-vs-Extreme_Obese |
3.21659999746871E-08 |
| Normal_Weight-vs-Extreme_Weight |
7.154800E-01 |
| Normal_Weight-vs-Obese |
3.814600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.011220E-01 |
| Extreme_Weight-vs-Obese |
3.166800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.614240E-02 |
| Obese-vs-Extreme_Obese |
1.117430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.49510000002628E-06 |
| Normal-vs-Age(41-60Yrs) |
1.78710000020565E-07 |
| Normal-vs-Age(61-80Yrs) |
2.64800000038257E-07 |
| Normal-vs-Age(81-100Yrs) |
2.44339999999621E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.297800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.182800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.225600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.014800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.768400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.543400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.59659999998674E-07 |
| Normal-VS-Type2 PRCC |
2.14090000172362E-08 |
| Normal-VS-KIRP CIMP |
2.25470000003725E-07 |
| Normal-VS-Unclassified PRCC |
1.64340000052832E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.031200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.755000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.985000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.442800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.416200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.628200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.76290000270174E-08 |
| Normal-vs-N1 |
2.60450000011403E-07 |
| Normal-vs-N2 |
3.328200E-02 |
| N0-vs-N1 |
1.793180E-01 |
| N0-vs-N2 |
3.847200E-01 |
| N1-vs-N2 |
9.764800E-01 |
|
|
